+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Serum Free Media Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786918
Global Serum Free Media Market Report and Forecast 2023-2031
Global Serum Free Media Market Outlook
The growth of the global serum free media market size is being driven by the increasing demand for cell-based vaccines across the globe. The market attained a value of USD 1.43 billion in 2022. The market is anticipated to grow at a CAGR of 10.04% during the forecast period of 2023-2031 to attain a value of USD 3.37 by 2031.

Serum Free Media: Introduction

Serum-free media (SFM) are cell culture media formulated without the use of animal serum or serum-derived components. Instead, SFM relies on defined components and growth factors that are chemically defined or derived from non-animal sources. SFM is widely used in the biopharmaceutical industry for the production of therapeutic proteins, vaccines, and other biologics.

SFM offers several advantages over serum-containing media, including batch-to-batch consistency, reduced risk of contamination by adventitious agents, and improved control over the quality and quantity of the product being produced. Additionally, the use of SFM can reduce the ethical concerns and variability associated with the use of animal serum in cell culture.

Overall, the use of SFM has become increasingly popular in the biopharmaceutical industry and it is expected to continue to grow in the coming years

Global Serum Free Media: Application and Uses

Serum-free media (SFM) are cell culture media formulated without animal-derived serum. SFMs have been developed to overcome the problems associated with serum-based media, such as contamination, lot-to-lot variation, and the potential presence of xenogeneic antigens, viruses, and prions. SFMs are used in various applications such as in vitro fertilization, stem cell research, monoclonal antibody production, vaccine production, and gene therapy. They are also used for the production of recombinant proteins and antibodies, particularly for biopharmaceuticals. SFMs have also found application in tissue engineering and regenerative medicine, particularly in the development of cell-based therapies.

Global Serum Free Media: Market Segmentations

Market Breakup by Media Type

  • Protein Expression Media
  • Stem Cell Media
  • Hybridoma Media
  • Primary Cell Media
  • Insect Cell Media
  • Immunology Media
  • CHO Cell Culture
  • Chemically Defined
  • Others

Market Breakup by End User

  • Biopharmaceutical Companies
  • Clinical Research Organisations
  • Academic Research Centres
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Global Serum Free Media Market Scenario

The increasing demand for cell-based vaccines and rising adoption of serum-free media in research and development activities are the major factors driving the growth of the market. In addition, the advantages of serum-free media over traditional serum-based media, such as reduced risk of contamination and batch-to-batch variability, are also contributing to the growth of the market.

North America is expected to dominate the market due to the presence of well-established pharmaceutical and biotechnology industries, as well as significant investments in R&D activities. The Asia-Pacific region is also expected to witness significant growth during the forecast period due to increasing investments in biotechnology and pharmaceutical sectors, rising demand for biologics, and growing government initiatives to support the development of the healthcare industry.

Key Players in the Global Serum Free Media Market

The report gives an in-depth analysis of the key players involved in the global serum free media market. The companies included in the market are as follows:
  • Lonza
  • Corning Incorporated
  • Nippon Genetics Co. Ltd
  • MP Biomedicals LLC
  • Danaher Corporation
  • PromoCell GmbH
  • Thermo Fisher Scientific, Inc
  • FUJIFILM Holdings Corporation
  • Illumina, Inc
  • Sigma Aldrich
  • HiMedia Laboratories

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Serum Free Media Market Overview
3.1 Global Serum Free Media Market Historical Value (2016-2022)
3.2 Global Serum Free Media Market Forecast Value (2023-2031)
4 Global Serum Free Media Market Landscape
4.1 Global Serum Free Media Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Serum Free Media Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Serum Free Media Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Serum Free Media Market Segmentation
6.1 Global Serum Free Media Market by Media Type
6.1.1 Market Overview
6.1.2 Protein Expression Media
6.1.3 Stem Cell Media
6.1.4 Hybridoma Media
6.1.5 Primary Cell Media
6.1.6 Insect Cell Media
6.1.7 Immunology Media
6.1.8 CHO Cell Culture
6.1.9 Chemically Defined
6.1.10 Others
6.2 Global Serum Free Media Market by End User
6.2.1 Market Overview
6.2.2 Biopharmaceutical Companies
6.2.3 Clinical Research Organisations
6.2.4 Academic Research Centers
6.2.5 Others
6.3 Global Serum Free Media Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Serum Free Media Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Serum Free Media Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Serum Free Media Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Serum Free Media Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Serum Free Media Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Lonza
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Corning Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Nippon Genetics Co. Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 MP Biomedicals LLC
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 PromoCell GmbH
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Thermo Fisher Scientific, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 FUJIFILM Holdings Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Illumina, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Sigma Aldrich
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HiMedia Laboratories
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Serum Free Media Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Lonza
  • Corning Incorporated
  • Nippon Genetics Co. Ltd.
  • Mp Biomedicals LLC
  • Danaher Corporation
  • Promocell GmbH
  • Thermo Fisher Scientific, Inc.
  • Fujifilm Holdings Corporation
  • Illumina, Inc.
  • Sigma Aldrich
  • Himedia Laboratories



Table Information